Center for Breakthrough Medicines Adds Two Senior Vice Presidents to Leadership Team

The Center for Breakthrough Medicines (CBM) announced today the appointment of Mandy Conver as Senior Vice President (SVP) of Business Development for Testing & Analytics, and Jennifer Manning as SVP of Global Strategic Partnerships.

Mandy Conver

"Both Mandy and Jennifer are accomplished and recognized leaders in the biotechnology industry and we are thrilled to have them join our team," said Joerg Ahlgrimm, Chief Executive Officer of CBM. "Each brings extensive expertise in strategy formulation, team development, process management and commercial leadership, and are expected to have a significant impact on the continued growth of CBM."

Jennifer Manning

"Mandy and Jennifer are leaders who have made significant contributions throughout their careers and each will continue to excel here at CBM," said Audrey Greenberg, CBM co-founder and Chief Business Officer. "Women are making meaningful impacts in the cell processing and biopharma industries, and CBM is proud to have several leadership and executive roles occupied by extremely well-qualified females."